Erika Chassagne

Outlook Microsoft Office 365 Viewpoint AI

biotechnology research gene therapy retinal diseases neurodegenerative diseases optogenetics inherited blindness clinical trials mitochondrial targeting sequence vision restoration leber hereditary optic neuropathy retinitis pigmentosa geographic atrophy ophthalmology biotechnology aav vectors drug development rare diseases patient solutions clinical development ophthalmic therapies genetically modified therapies regulatory affairs biopharmaceuticals medical devices scientific research biotech industry therapeutic strategies pharmaceutical development ocular diseases biotech investments genetic engineering clinical operations pre-clinical studies pharmacovigilance market access biotech commercialization healthcare innovation medical biotechnology eye care vision treatments biotech collaborations research & development investor relations biotech funding advanced therapies scientific excellence biomedical research ophthalmologic interventions health care health wellness & fitness hospital & health care